Inventor · disambiguated record
Andrew Simmons
Also filed as: SIMMONS ANDREW · SIMMONS ANDREW D · SIMMONS ANDREW DAVID
7 granted patents·4 pending applications·262 citations·filing 2002–2021
89Inventor score
Files withBIOSANTE PHARMACEUTICALS INC5CELL GENESYS INC2ALKERMES PHARMA IRELAND LTD1FANG JIANMIN1GBP IP LLC1
Top patents by PatentIndex Score
11 records- 0196US7179903B2Liver specific transcriptional enhancerCELL GENESYS INC·Filed 2004·Granted Feb 20, 2007·89 cites·9 claims
- 0295US6808905B2Lentiviral vectors encoding clotting factors for gene therapyCELL GENESYS INC·Filed 2002·Granted Oct 26, 2004·64 cites·33 claims
- 0393US7919079B2Cancer immunotherapy compositions and methods of useBIOSANTE PHARMACEUTICALS INC·Filed 2007·Granted Apr 5, 2011·16 cites·28 claims
- 0493US7745179B2Lentiviral vectors featuring liver specific transcriptional enhancer and methods of using sameGBP IP LLC·Filed 2007·Granted Jun 29, 2010·53 cites·28 claims
- 0591US7662623B2Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage siteBIOSANTE PHARMACEUTICALS INC·Filed 2007·Granted Feb 16, 2010·14 cites·6 claims
- 0689US7709224B2Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage siteBIOSANTE PHARMACEUTICALS INC·Filed 2004·Granted May 4, 2010·19 cites·7 claims
- 0783US7632509B2Methods to express recombinant proteins from lentiviral vectorsBIOSANTE PHARMACEUTICALS INC·Filed 2006·Granted Dec 15, 2009·7 cites·16 claims
- 0856US2011028694A1Methods to express recombinant proteins from lentiviral vectorsFANG JIANMIN·Filed 2009·Application pending·0 cites
- 0952US2013309267A1Cancer immunotherapy compositions and methods of useSIMMONS ANDREW·Filed 2011·Application pending·0 cites
- 1050US2011038801A1Methods and compositions for identifying lung cancer or a humoral immune response against lung cancerBIOSANTE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1150US2021338656A1Immunostimulatory agents in combination with angiogenesis inhibitorsALKERMES PHARMA IRELAND LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Simmons files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →